Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 3 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Breast 3Head & Neck 1Gynecologic 1CNS 1

Conditions

Breast Neoplasms 91Neoplasm Metastasis 24Neoplasms 14Brain Neoplasms 13Prostatic Neoplasms 10Endometrial Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Ovarian Neoplasms 7Glioblastoma 7Glioma 6Triple Negative Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Head and Neck Neoplasms 5Colorectal Neoplasms 5Sarcoma 4Recurrence 4Pancreatic Neoplasms 4Lymphoma, Non-Hodgkin 4Sarcoma, Ewing 3Osteosarcoma 3Neoplasms by Site 3Multiple Myeloma 3Meningioma 3Melanoma 3Carcinoma, Renal Cell 3Breast Diseases 3Unilateral Breast Neoplasms 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Oligodendroglioma 2

Interventions

exemestane 7Trastuzumab 7Anastrozole 7Letrozole 6Docetaxel 6palbociclib 5pyrotinib 4entinostat 4Fulvestrant 4Cyclophosphamide 4ribociclib 3abemaciclib 3Tamoxifen 3Doxorubicin 3pertuzumab 2Sodium Chloride 2Paclitaxel 2Lapatinib 2Gonadotropin-Releasing Hormone 2Exercise 2Everolimus 2Epirubicin 2Drug Evaluation 2Capecitabine 2Botulinum Toxins, Type A 2Aromatase Inhibitors 2AZD9833 2trastuzumab deruxtecan 1taxane 1sacubitril and valsartan sodium hydrate drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Breast Diseases × abemaciclib × Clear all
NCT05768139 2026-05-22

PIKALO-1

Eli Lilly and Company

Phase 1/2 Recruiting
880 enrolled
BreastGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Breast Diseases, Breast Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Neoplasms, Neoplasms by Site, Hereditary Sensory and Autonomic Neuropathies, Ovarian Neoplasms, Endometrial Neoplasms

NCT04964934 2026-04-21

SERENA-6

AstraZeneca

Phase 3 Active not recruiting
315 enrolled
Breast

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site

NCT05386108 2026-04-06

ELECTRA

Stemline Therapeutics, Inc.

Phase 1/2 Recruiting
73 enrolled
BreastCNS

Brain Diseases, Brain Neoplasms, Breast Diseases, Breast Neoplasms, Central Nervous System Diseases, Neoplasms, Neoplasms by Site, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡